Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 12:32 AM
NCT ID:
NCT00510367
Eligibility Criteria:
Inclusion Criteria:
ยท All patients with primary breast cancer occurring during pregnancy will be eligible for enrollment.
Exclusion Criteria:
* Patients presenting with systemic metastases at time of diagnosis.
* Patients unwilling or unable to give informed consent.
* Patients who have received radiation therapy while pregnant
* Patients who have received chemotherapy during the first trimester of pregnancy or chemotherapy other than FAC.
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT00510367
Study Brief:
Protocol Section:
NCT00510367